Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2885
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04444050 | Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986331 in Healthy Participants | ||
| NCT03195478 | A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors | ||
| NCT05287568 | CC-486 and Venetoclax for Acute Myeloid Leukemia | ||
| NCT05413018 | An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission | ||
| NCT00279760 | Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis | ||
| NCT02588625 | A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) | ||
| NCT00992420 | Genotype Information and Functional Testing Study | ||
| NCT03552380 | Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma | ||
| NCT02832180 | The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects | ||
| NCT01170533 | PPI and Clopidogrel Response | ||
| NCT01106534 | XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort | ||
| NCT00174876 | Aripiprazole as Augmentation for TRD | ||
| NCT02913313 | A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors | ||
| NCT07221357 | A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer | ||
| NCT00390936 | A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors | ||
| NCT02576509 | An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma | ||
| NCT01246765 | National Pregnancy Registry for Psychiatric Medications | ||
| NCT00859898 | Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes | ||
| NCT00656734 | Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. | ||
| NCT04267393 | Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH) | ||
| NCT03071133 | Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy | ||
| NCT01217892 | Evaluation of Dapagliflozin Taken Twice-daily | ||
| NCT02654132 | An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3) | ||
| NCT03402087 | A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients | ||
| NCT04161781 | A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer | ||
| NCT02305563 | An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia | ||
| NCT01393964 | Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function | ||
| NCT03547999 | A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC | ||
| NCT00114777 | Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant | ||
| NCT00211263 | Bipolar Disorder Research Study for Ages 12 and Older | ||
| NCT05625412 | A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors | ||
| NCT00194012 | Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder | ||
| NCT04301414 | Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer | ||
| NCT03425461 | Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma | ||
| NCT01173120 | Methotrexate - Inadequate Response Device Sub-Study | ||
| NCT02327403 | Belatacept Conversion in Proteinuric Kidney Transplant Recipients | ||
| NCT00382460 | Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22) | ||
| NCT00225017 | Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study | ||
| NCT05123950 | A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe | ||
| NCT03500562 | Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC) | ||
| NCT06926868 | A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) | ||
| NCT00862823 | The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers | ||
| NCT02845323 | Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder | ||
| NCT05702879 | Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success | ||
| NCT02846376 | Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant | ||
| NCT00237874 | Aripiprazole Treatment of Prodromal Patients | ||
| NCT05498480 | Study of Relatlimab in Combination With Nivolumab in Chinese Participants | ||
| NCT05162443 | Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation | ||
| NCT03363776 | An Investigational Immuno-Therapy Study of Experimental Medication BMS-986277 Given Alone and in Combination With Nivolumab in Epithelial Cancers | ||
| NCT05472623 | Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab |
